On the evening of October 25, the Grand Ballroom at The Plaza in New York City was buzzing with excitement. The Skin Cancer Foundation was holding its 22nd annual Gala, the organization’s signature fundraiser. The event raised over $600,000 to support SCF initiatives,and also provided a chance to honor leaders in the skin cancer space […]
While skin cancers are less commonly diagnosed in areas that are normally shielded from the sun, they can and do develop there.
As we get ready to announce our 2018 Media Award winner, we caught up with past recipient Jenna Rosenstein, who won for her article highlighting indoor tanning on campuses. Two years later, the impact of the article is still reverberating and remains an important topic of conversation.
You don’t have to run out and buy Apple’s fancy new phone to get a high-tech boost for your skin surveillance. In fact, a basic phone with a camera is all you need!
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
Your eyes can focus on a tiny splinter in the finger of a squirming child, a stop sign in the distance or stars blinking light-years away. You can roll your eyes, flirt with them, do a double-take and express joy or despair without words. When you think about how amazing your eyes are, wouldn’t you do anything to protect them?
Certain types of skin are at greater risk for developing sun damage and skin cancer. Do you know your skin type?